ATE220065T1 - Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten - Google Patents

Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten

Info

Publication number
ATE220065T1
ATE220065T1 AT97104774T AT97104774T ATE220065T1 AT E220065 T1 ATE220065 T1 AT E220065T1 AT 97104774 T AT97104774 T AT 97104774T AT 97104774 T AT97104774 T AT 97104774T AT E220065 T1 ATE220065 T1 AT E220065T1
Authority
AT
Austria
Prior art keywords
group
heart disease
alkyl group
benzopyran derivative
treatment
Prior art date
Application number
AT97104774T
Other languages
English (en)
Inventor
Hidetsugu Takagaki
Nobuyuki Kimura
Yasuo Aoki
Shigenori Nakanishi
Masayoshi Abe
Osamu Misumi
Original Assignee
Dainippon Ink & Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Ink & Chemicals filed Critical Dainippon Ink & Chemicals
Application granted granted Critical
Publication of ATE220065T1 publication Critical patent/ATE220065T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97104774T 1996-03-22 1997-03-20 Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten ATE220065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6610296 1996-03-22
JP00457597A JP3885900B2 (ja) 1996-03-22 1997-01-14 ベンゾピラン誘導体及びそれを有効成分とする心臓疾患治療剤

Publications (1)

Publication Number Publication Date
ATE220065T1 true ATE220065T1 (de) 2002-07-15

Family

ID=26338386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97104774T ATE220065T1 (de) 1996-03-22 1997-03-20 Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten

Country Status (10)

Country Link
US (1) US5981495A (de)
EP (1) EP0796854B1 (de)
JP (1) JP3885900B2 (de)
KR (1) KR100574907B1 (de)
CN (1) CN1101678C (de)
AT (1) ATE220065T1 (de)
AU (1) AU726901B2 (de)
CA (1) CA2200516C (de)
DE (1) DE69713648T2 (de)
TW (1) TW502030B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809820B1 (fr) 2000-05-30 2002-10-25 Proteus Methode de detection d'une transformation d'un substrat et ses applications
EP1273578B1 (de) * 2001-06-28 2005-02-23 Dainippon Ink And Chemicals, Inc. Benzopyran Derivate und diese enthaltende antiallergisches Mittel
FR2832729B1 (fr) 2001-11-28 2004-01-16 Proteus Methode de detection d'une activite catalytique d'un echantillon mettant en oeuvre la detection de la transformation d'un substrat
CN1506359A (zh) * 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
JP2006193494A (ja) * 2005-01-17 2006-07-27 Dainippon Ink & Chem Inc ４級アンモニウム系化合物を有効成分とする心臓疾患治療剤
KR20080059653A (ko) * 2005-10-25 2008-06-30 액티버스 파마 컴퍼니 리미티드 순환 부전 치료제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845121A (en) * 1986-06-13 1989-07-04 The Ohio State University Research Foundation Aci-reductone compounds belonging to the 6,7-disubstituted-3,4-dihydro benzopyan-2H-one class having antiaggregatory properties
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
JP3225518B2 (ja) * 1991-01-31 2001-11-05 大日本インキ化学工業株式会社 ベンゾピラン誘導体並びにそれを有効成分とする抗アレルギー剤
JP3831953B2 (ja) * 1994-05-23 2006-10-11 大日本インキ化学工業株式会社 ７−グリコシロキシベンゾピラン誘導体及びそれを有効成分とする抗アレルギー剤

Also Published As

Publication number Publication date
DE69713648T2 (de) 2002-11-21
TW502030B (en) 2002-09-11
JP3885900B2 (ja) 2007-02-28
EP0796854A1 (de) 1997-09-24
KR970064604A (ko) 1997-10-13
US5981495A (en) 1999-11-09
CA2200516C (en) 2007-06-26
AU726901B2 (en) 2000-11-23
CN1101678C (zh) 2003-02-19
CN1164999A (zh) 1997-11-19
CA2200516A1 (en) 1997-09-22
KR100574907B1 (ko) 2006-07-06
JPH09315967A (ja) 1997-12-09
AU1645897A (en) 1997-09-25
EP0796854B1 (de) 2002-07-03
DE69713648D1 (de) 2002-08-08

Similar Documents

Publication Publication Date Title
DE3876877T2 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE69109631T2 (de) 2-Substituierte Adenosinderivate und pharmazeutische Zusammensetzungen zur Verwendung gegen Infektionskrankheiten.
DK1136474T3 (da) 1-Acetyl-5-brom-4,6-dimethylindolin
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ATE220065T1 (de) Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten
NO172640C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinderivater
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE168690T1 (de) Indolderivate, ihre salze und sie enthaltende arzneimittel zur behandlung von herzkrankheiten
KR890001555A (ko) 요산 배설용 조성물
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE69722630D1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner